Thursday, October 6, 2022

Glenmark launches drug to treat patients with insulin-resistant diabetes

Glenmark launches drug to treat patients with insulin-resistant diabetes The Mumbai-based drug firm has launched the medication under the brand name LOBG and is priced at around Rs 10 per tablet.

from Moneycontrol Business News https://ift.tt/eG8Swco

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...